OAM
CMD

Oppenheimer Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Oppenheimer Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,619
Closed -$285K – 1224
2020
Q4 		$285K Sell
3,619
-1,027
-22% -$60.2K ﹤0.01% 1001
2020
Q3 		$204K Sell
4,646
-3,697
-44% -$182K ﹤0.01% 1024
2020
Q2 		$369K Sell
8,343
-3,033
-27% -$113K 0.01% 871
2020
Q1 		$408K Sell
11,376
-572
-5% -$32.5K 0.01% 791
2019
Q4 		$847K Sell
11,948
-355
-3% -$25.8K 0.02% 673
2019
Q3 		$921K Buy
12,303
+759
+7% +$64.3K 0.02% 634
2019
Q2 		$931K Buy
11,544
+365
+3% +$25.7K 0.02% 641
2019
Q1 		$748K Buy
11,179
+3,094
+38% +$234K 0.02% 688
2018
Q4 		$602K Sell
8,085
-13,760
-63% -$1.14M 0.01% 701
2018
Q3 		$2.01M Buy
21,845
+1,025
+5% +$97.6K 0.04% 413
2018
Q2 		$2.05M Buy
20,820
+117
+0.6% +$13.1K 0.05% 394
2018
Q1 		$2.31M Buy
20,703
+4,974
+32% +$557K 0.06% 347
2017
Q4 		$1.48M Hold
15,729
– – 0.04% 467
2017
Q3 		$1.48M Buy
15,729
+696
+5% +$54.9K 0.04% 469
2017
Q2 		$1.17M Buy
15,033
+132
+0.9% +$9.91K 0.03% 534
2017
Q1 		$1.19M Buy
+14,901
New +$1.18M 0.03% 511

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Oppenheimer Asset Management's CMD Position: Q1 2021 in Review

Oppenheimer Asset Management sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 3,619 shares — an estimated $285K sold.

Oppenheimer Asset Management first reported a position in CMD in Q1 2017 and held it in 16 quarters. The position peaked at $2.31M in Q1 2018. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Oppenheimer Asset Management reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Oppenheimer Asset Management sold 3,619 Cantel Medical Corporation shares in Q1 2021, an estimated $285K.
  • Oppenheimer Asset Management first reported a position in Cantel Medical Corporation in Q1 2017 and held it in 16 quarters.
  • Oppenheimer Asset Management's Cantel Medical Corporation position peaked at $2.31M in Q1 2018.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Oppenheimer Asset Management's 13F filing for Q1 2021, filed 17 May 2021.